Bonner Michael 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 23, 2018
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2018-03-19$6.72/sh+300$2,016→ 15,997 total - Tax Payment
Common Stock
2018-03-23$6.70/sh−843$5,648→ 17,654 total - Award
Common Stock
2018-03-23$6.70/sh+2,500$16,750→ 18,497 total
Footnotes (2)
- [F1]Restricted stock award will vest 100% on March 20, 2022.
- [F2]This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.